A vanillin derivative causes mitochondrial dysfunction and triggers oxidative stress in Cryptococcus neoformans

Area of Science:

• Mycology
• Medicinal Chemistry
• Molecular Biology

Background:

• Vanillin, a common additive, possesses antioxidant and antimutagenic properties.
• Its antifungal activity against human pathogens is limited.
• Cryptococcus neoformans causes meningitis, particularly in immunocompromised individuals.

Purpose of the Study:

• To investigate the antifungal potential of vanillin derivatives against Cryptococcus neoformans.
• To identify structural features of vanillin derivatives that enhance antifungal activity.
• To elucidate the mechanism of action of potent vanillin derivatives.

Main Methods:

• Screening of 33 vanillin derivatives for antifungal activity against C. neoformans.
• Structure-activity relationship analysis.
• RNA sequencing to analyze gene expression changes in response to o-vanillin treatment.
• Gene knockout studies to validate antifungal mechanisms.

Main Results:

• A structure-activity relationship was established, with hydroxyl or alkoxy groups being more effective than halogenated or nitrated groups.
• O-vanillin and o-ethyl vanillin exhibited the highest antifungal activity.
• O-vanillin treatment led to mitochondrial dysfunction and oxidative stress in C. neoformans.
• Mutants deficient in mitochondrial function or oxidative stress response showed reduced susceptibility to o-vanillin.

Conclusions:

• Vanillin derivatives, particularly o-vanillin, demonstrate significant antifungal activity against Cryptococcus neoformans.
• The antifungal mechanism involves mitochondrial dysfunction and oxidative stress induction.
• O-vanillin represents a promising lead compound for developing new antifungal agents.